Oxygen Sensors at the Crossroad of Metabolism

Cell Metabolism

Volumn 9, Issue 1, 2009, Pages 11-22

  Aragonés, Julián ^a,b   Fraisl, Peter ^a,b   Baes, Myriam ^a   Carmeliet, Peter ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

HUMDISEASE

Indexed keywords

2 OXOGLUTARIC ACID; CARBONATE DEHYDRATASE IX; DIOXYGENASE; FATTY ACID; FENOFIBRATE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HEMOGLOBIN; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LACTATE DEHYDROGENASE; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PYRUVATE DEHYDROGENASE; SODIUM PROTON EXCHANGE PROTEIN 1;

AEROBIC METABOLISM; ANAEROBIC METABOLISM; ANGIOGENESIS; CELL METABOLISM; DAPHNIA; DROSOPHILA; ENERGY CONSERVATION; ERYTHROPOIESIS; FATTY ACID OXIDATION; GLUCOSE OXIDATION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIA; LIVER ISCHEMIA; LUNG VENTILATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; OXYGEN SENSING; OXYGEN SUPPLY; OXYGEN TRANSPORT; PH; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASODILATATION;

ANIMALS; FATTY ACIDS; GLUCOSE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; MICE; OXYGEN CONSUMPTION; OXYGENASES; PROCOLLAGEN-PROLINE DIOXYGENASE; SIGNAL TRANSDUCTION;

EID: 57849163103     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2008.10.001     Document Type: Review

References (95)

1. Andrews R.M. Low oxygen: a constraint on the evolution of viviparity in reptiles. Physiol. Biochem. Zool. 75 (2002) 145-154
2. Aragones J., Schneider M., Van Geyte K., Fraisl P., Dresselaers T., Mazzone M., Dirkx R., Zacchigna S., Lemieux H., Jeoung N.H., et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40 (2008) 170-180
3. Berra E., Ginouves A., and Pouyssegur J. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep. 7 (2006) 41-45
4. Bracken C.P., Fedele A.O., Linke S., Balrak W., Lisy K., Whitelaw M.L., and Peet D.J. Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment. J. Biol. Chem. 281 (2006) 22575-22585
5. Braun R.D., Lanzen J.L., Snyder S.A., and Dewhirst M.W. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H2533-H2544
6. Brugarolas J., Lei K., Hurley R.L., Manning B.D., Reiling J.H., Hafen E., Witters L.A., Ellisen L.W., and Kaelin Jr. W.G. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18 (2004) 2893-2904
7. Bruick R.K., and McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001) 1337-1340
8. Brunelle J.K., Bell E.L., Quesada N.M., Vercauteren K., Tiranti V., Zeviani M., Scarpulla R.C., and Chandel N.S. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1 (2005) 409-414
9. Calvisi D.F., Ladu S., Gorden A., Farina M., Lee J.S., Conner E.A., Schroeder I., Factor V.M., and Thorgeirsson S.S. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. 117 (2007) 2713-2722
10. Carey H.V., Andrews M.T., and Martin S.L. Mammalian hibernation: cellular and molecular responses to depressed metabolism and low temperature. Physiol. Rev. 83 (2003) 1153-1181
11. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
12. Cash T.P., Pan Y., and Simon M.C. Reactive oxygen species and cellular oxygen sensing. Free Radic. Biol. Med. 43 (2007) 1219-1225
13. Chow D.C., Wenning L.A., Miller W.M., and Papoutsakis E.T. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys. J. 81 (2001) 685-696
14. Dahia P.L., Ross K.N., Wright M.E., Hayashida C.Y., Santagata S., Barontini M., Kung A.L., Sanso G., Powers J.F., Tischler A.S., et al. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet. 1 (2005) 72-80
15. Dang C.V., Kim J.W., Gao P., and Yustein J. The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 8 (2008) 51-56
16. Dayan F., Roux D., Brahimi-Horn M.C., Pouyssegur J., and Mazure N.M. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res. 66 (2006) 3688-3698
17. DeBerardinis R.J., Lum J.J., Hatzivassiliou G., and Thompson C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7 (2008) 11-20
18. Di Giulio C., Bianchi G., Cacchio M., Artese L., Rapino C., Macri M.A., and Di Ilio C. Oxygen and life span: chronic hypoxia as a model for studying HIF-1alpha, VEGF and NOS during aging. Respir. Physiolo. Neurobiol. 147 (2005) 31-38
19. Druzhyna N.M., Wilson G.L., and LeDoux S.P. Mitochondrial DNA repair in aging and disease. Mech. Ageing Dev. 129 (2008) 383-390
20. Eckle T., Kohler D., Lehmann R., El Kasmi K., and Eltzschig H.K. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118 (2008) 166-175
21. Ehrismann D., Flashman E., Genn D.N., Mathioudakis N., Hewitson K.S., Ratcliffe P.J., and Schofield C.J. Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. Biochem. J. 401 (2007) 227-234
22. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
23. Erecinska M., and Silver I.A. Tissue oxygen tension and brain sensitivity to hypoxia. Respir. Physiol. 128 (2001) 263-276
24. Finck B.N., Bernal-Mizrachi C., Han D.H., Coleman T., Sambandam N., LaRiviere L.L., Holloszy J.O., Semenkovich C.F., and Kelly D.P. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. Cell Metab. 1 (2005) 133-144
25. Fukuda R., Zhang H., Kim J.W., Shimoda L., Dang C.V., and Semenza G.L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129 (2007) 111-122
26. Gatenby R.A., and Gillies R.J. A microenvironmental model of carcinogenesis. Nat. Rev. Cancer 8 (2008) 56-61
27. Gnaiger E., Lassnig B., Kuznetsov A., Rieger G., and Margreiter R. Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J. Exp. Biol. 201 (1998) 1129-1139
28. Gorr T.A., Gassmann M., and Wappner P. Sensing and responding to hypoxia via HIF in model invertebrates. J. Insect Physiol. 52 (2006) 349-364
29. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., and Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1 (2005) 401-408
30. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2 (2002) 38-47
31. Helmlinger G., Yuan F., Dellian M., and Jain R.K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3 (1997) 177-182
32. Heusch G., Schulz R., and Rahimtoola S.H. Myocardial hibernation: a delicate balance. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H984-H999
33. Hill P., Shukla D., Tran M.G., Aragones J., Cook H.T., Carmeliet P., and Maxwell P.H. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 19 (2008) 39-46
34. Huss J.M., Levy F.H., and Kelly D.P. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J. Biol. Chem. 276 (2001) 27605-27612
35. Isaacs J.S., Jung Y.J., Mole D.R., Lee S., Torres-Cabala C., Chung Y.L., Merino M., Trepel J., Zbar B., Toro J., et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8 (2005) 143-153
36. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., Gassmann M., Gearhart J.D., Lawler A.M., Yu A.Y., and Semenza G.L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12 (1998) 149-162
37. Kaelin Jr. W.G., and Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30 (2008) 393-402
38. Kasiganesan H., Sridharan V., and Wright G. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance. Acta. Physiol. (Oxf) 190 (2007) 163-169
39. Kato H., Inoue T., Asanoma K., Nishimura C., Matsuda T., and Wake N. Induction of human endometrial cancer cell senescence through modulation of HIF-1alpha activity by EGLN1. Int. J. Cancer 118 (2006) 1144-1153
40. Kim J.W., Tchernyshyov I., Semenza G.L., and Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3 (2006) 177-185
41. Koivunen P., Hirsila M., Gunzler V., Kivirikko K.I., and Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J. Biol. Chem. 279 (2004) 9899-9904
42. Koivunen P., Tiainen P., Hyvarinen J., Williams K.E., Sormunen R., Klaus S.J., Kivirikko K.I., and Myllyharju J. An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha. J. Biol. Chem. 282 (2007) 30544-30552
43. Kroemer G., and Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13 (2008) 472-482
44. Kulkarni A.C., Kuppusamy P., and Parinandi N. Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. Antioxid. Redox Signal. 9 (2007) 1717-1730
45. Lando D., Gorman J.J., Whitelaw M.L., and Peet D.J. Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. Eur. J. Biochem. 270 (2003) 781-790
46. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002) 1466-1471
47. Lefebvre P., Chinetti G., Fruchart J.C., and Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 116 (2006) 571-580
48. Leichtweiss H.P., Lubbers D.W., Weiss C., Baumgartl H., and Reschke W. The oxygen supply of the rat kidney: measurements of intrarenal pO2. Pflugers Arch. 309 (1969) 328-349
49. Liu L., and Simon M.C. Regulation of transcription and translation by hypoxia. Cancer Biol. Ther. 3 (2004) 492-497
50. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., and Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280 (2005) 41928-41939
51. Lu C.W., Lin S.C., Chen K.F., Lai Y.Y., and Tsai S.J. Induction of pyruvate dehydrogenase kinase 3 by HIF-1 promotes metabolic switch and drug resistance. J. Biol. Chem. (2008) 10.1074/jbc.M803508200
52. Mansfield K.D., Guzy R.D., Pan Y., Young R.M., Cash T.P., Schumacker P.T., and Simon M.C. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab. 1 (2005) 393-399
53. Mariani J., Ou R., Bailey M., Rowland M., Nagley P., Rosenfeldt F., and Pepe S. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J. Thorac. Cardiovasc. Surg. 120 (2000) 660-667
54. May D., Gilon D., Djonov V., Itin A., Lazarus A., Gordon O., Rosenberger C., and Keshet E. Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc. Natl. Acad. Sci. USA 105 (2008) 282-287
55. Minamishima Y.A., Moslehi J., Bardeesy N., Cullen D., Bronson R.T., and Kaelin Jr. W.G. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111 (2008) 3236-3244
56. Narravula S., and Colgan S.P. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J. Immunol. 166 (2001) 7543-7548
57. Ockaili R., Natarajan R., Salloum F., Fisher B.J., Jones D., Fowler III A.A., and Kukreja R.C. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H542-H548
58. Ohneda O., Nagano M., and Fujii-Kuriyama Y. Role of hypoxia-inducible factor-2alpha in endothelial development and hematopoiesis. Methods Enzymol. 435 (2007) 199-218
59. Okaya T., and Lentsch A.B. Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 286 (2004) G606-G612
60. Papandreou I., Cairns R.A., Fontana L., Lim A.L., and Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3 (2006) 187-197
61. Percy M.J., Zhao Q., Flores A., Harrison C., Lappin T.R., Maxwell P.H., McMullin M.F., and Lee F.S. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. USA 103 (2006) 654-659
62. Percy M.J., Furlow P.W., Beer P.A., Lappin T.R., McMullin M.F., and Lee F.S. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. Blood 110 (2007) 2193-2196
63. Philipp S., Cui L., Ludolph B., Kelm M., Schulz R., Cohen M.V., and Downey J.M. Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H450-H457
64. Pouyssegur J., Dayan F., and Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
65. Ramirez J.M., Folkow L.P., and Blix A.S. Hypoxia tolerance in mammals and birds: from the wilderness to the clinic. Annu. Rev. Physiol. 69 (2007) 113-143
66. Rohrbach S., Teichert S., Niemann B., Franke C., and Katschinski D.M. Caloric restriction counteracts age-dependent changes in prolyl-4-hydroxylase domain (PHD) 3 expression. Biogerontology 9 (2008) 169-176
67. Safran M., and Kaelin Jr. W.G. HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Invest. 111 (2003) 779-783
68. Sambandam N., Morabito D., Wagg C., Finck B.N., Kelly D.P., and Lopaschuk G.D. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H87-H95
69. Schofield C.J., and Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5 (2004) 343-354
70. Schuler M., Ali F., Chambon C., Duteil D., Bornert J.M., Tardivel A., Desvergne B., Wahli W., Chambon P., and Metzger D. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab. 4 (2006) 407-414
71. Scortegagna M., Ding K., Oktay Y., Gaur A., Thurmond F., Yan L.J., Marck B.T., Matsumoto A.M., Shelton J.M., Richardson J.A., et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat. Genet. 35 (2003) 331-340
72. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., Pan Y., Simon M.C., Thompson C.B., and Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 (2005) 77-85
73. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
74. Semenza G.L. Life with oxygen. Science 318 (2007) 62-64
75. Shimoda L.A., Fallon M., Pisarcik S., Wang J., and Semenza G.L. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 291 (2006) L941-L949
76. Simon M.C., and Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat. Rev. Mol. Cell Biol. 9 (2008) 285-296
77. Simonides W.S., Mulcahey M.A., Redout E.M., Muller A., Zuidwijk M.J., Visser T.J., Wassen F.W., Crescenzi A., da-Silva W.S., Harney J., et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J. Clin. Invest. 118 (2008) 975-983
78. Singer D., and Muhlfeld C. Perinatal adaptation in mammals: the impact of metabolic rate. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 148 (2007) 780-784
79. Sridharan V., Guichard J., Bailey R.M., Kasiganesan H., Beeson C., and Wright G.L. The prolyl hydroxylase oxygen-sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibition. Am. J. Physiol. Cell Physiol. 292 (2007) C719-C728
80. Sridharan V., Guichard J., Li C.Y., Muise-Helmericks R., Beeson C.C., and Wright G.L. O(2)-sensing signal cascade: clamping of O(2) respiration, reduced ATP utilization, and inducible fumarate respiration. Am. J. Physiol. Cell Physiol. 295 (2008) C29-C37
81. Takeda K., and Fong G.H. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation. Hypertension 49 (2007) 178-184
82. Takeda K., Cowan A., and Fong G.H. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 116 (2007) 774-781
83. Takeda K., Aguila H.L., Parikh N.S., Li X., Lamothe K., Duan L.J., Takeda H., Lee F.S., and Fong G.H. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111 (2008) 3229-3235
84. Tang N., Wang L., Esko J., Giordano F.J., Huang Y., Gerber H.P., Ferrara N., and Johnson R.S. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6 (2004) 485-495
85. Ullah M.S., Davies A.J., and Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J. Biol. Chem. 281 (2006) 9030-9037
86. Vincent K.A., Shyu K.G., Luo Y., Magner M., Tio R.A., Jiang C., Goldberg M.A., Akita G.Y., Gregory R.J., and Isner J.M. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 102 (2000) 2255-2261
87. Ward J.P. Oxygen sensors in context. Biochim. Biophys. Acta 1777 (2008) 1-14
88. Weidemann A., and Johnson R.S. Biology of HIF-1alpha. Cell Death Differ. 15 (2008) 621-627
89. Welford S.M., Bedogni B., Gradin K., Poellinger L., Broome Powell M., and Giaccia A.J. HIF1alpha delays premature senescence through the activation of MIF. Genes Dev. 20 (2006) 3366-3371
90. Wiesener M.S., Turley H., Allen W.E., Willam C., Eckardt K.U., Talks K.L., Wood S.M., Gatter K.C., Harris A.L., Pugh C.W., et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92 (1998) 2260-2268
91. Wykoff C.C., Beasley N.J., Watson P.H., Turner K.J., Pastorek J., Sibtain A., Wilson G.D., Turley H., Talks K.L., Maxwell P.H., et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60 (2000) 7075-7083
92. Yatabe N., Kyo S., Maida Y., Nishi H., Nakamura M., Kanaya T., Tanaka M., Isaka K., Ogawa S., and Inoue M. HIF-1-mediated activation of telomerase in cervical cancer cells. Oncogene 23 (2004) 3708-3715
93. Yue T.L., Bao W., Jucker B.M., Gu J.L., Romanic A.M., Brown P.J., Cui J., Thudium D.T., Boyce R., Burns-Kurtis C.L., et al. Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury. Circulation 108 (2003) 2393-2399
94. Zhang H., Gao P., Fukuda R., Kumar G., Krishnamachary B., Zeller K.I., Dang C.V., and Semenza G.L. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11 (2007) 407-420
95. Zhang H., Bosch-Marce M., Shimoda L.A., Tan Y.S., Baek J.H., Wesley J.B., Gonzalez F.J., and Semenza G.L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 283 (2008) 10892-10903